{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:59:11Z","timestamp":1787763551392,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-374","type":"journal-article","created":{"date-parts":[[2012,12,23]],"date-time":"2012-12-23T18:14:16Z","timestamp":1356286456000},"source":"Crossref","is-referenced-by-count":16,"title":["Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load"],"prefix":"10.1186","volume":"12","author":[{"given":"Sabri Saeed","family":"Sanabani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youko","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Charlys","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Soares","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Pess\u00f4a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Eudes","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluisio C","family":"Segurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esper Georges","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Cerdeira","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,23]]},"reference":[{"issue":"12","key":"2175_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980, 77 (12): 7415-7419. 10.1073\/pnas.77.12.7415.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2175_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0736-4679(99)00173-0","volume":"18","author":"RF Edlich","year":"2000","unstructured":"Edlich RF, Arnette JA, Williams FM: Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000, 18 (1): 109-119. 10.1016\/S0736-4679(99)00173-0.","journal-title":"J Emerg Med"},{"issue":"33","key":"2175_CR3","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/sj.onc.1206551","volume":"22","author":"M Matsuoka","year":"2003","unstructured":"Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003, 22 (33): 5131-5140. 10.1038\/sj.onc.1206551.","journal-title":"Oncogene"},{"issue":"4","key":"2175_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007, 7 (4): 266-281. 10.1016\/S1473-3099(07)70081-6.","journal-title":"Lancet Infect Dis"},{"key":"2175_CR5","first-page":"409","volume-title":"Hematology (Am Soc Hematol Educ Program)","author":"G Franchini","year":"2000","unstructured":"Franchini G, Ambinder RF, Barry M: Viral Disease in Hematology. Hematology (Am Soc Hematol Educ Program). 2000, 409-423."},{"issue":"2","key":"2175_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ijc.2910430214","volume":"43","author":"EL Murphy","year":"1989","unstructured":"Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA: Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989, 43 (2): 250-253. 10.1002\/ijc.2910430214.","journal-title":"Int J Cancer"},{"issue":"Suppl 2","key":"2175_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF03165123","volume":"76","author":"K Yamaguchi","year":"2002","unstructured":"Yamaguchi K, Watanabe T: Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol. 2002, 76 (Suppl 2): 240-245.","journal-title":"Int J Hematol"},{"issue":"4","key":"2175_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007, 7 (4): 270-280. 10.1038\/nrc2111.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2175_CR9","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K: Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984, 81 (8): 2534-2537. 10.1073\/pnas.81.8.2534.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2175_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","volume":"109","author":"S Takeda","year":"2004","unstructured":"Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, Tanaka Y, Matsuoka M: Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004, 109 (4): 559-567. 10.1002\/ijc.20007.","journal-title":"Int J Cancer"},{"issue":"13","key":"2175_CR11","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1182\/blood-2006-03-007732","volume":"108","author":"JM Mesnard","year":"2006","unstructured":"Mesnard JM, Barbeau B, Devaux C: HBZ, a new important player in the mystery of adult T-cell leukemia. Blood. 2006, 108 (13): 3979-3982. 10.1182\/blood-2006-03-007732.","journal-title":"Blood"},{"issue":"2","key":"2175_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2007-1007107","volume":"19","author":"MJ Koziel","year":"1999","unstructured":"Koziel MJ: Cytokines in viral hepatitis. Semin Liver Dis. 1999, 19 (2): 157-169. 10.1055\/s-2007-1007107.","journal-title":"Semin Liver Dis"},{"issue":"9","key":"2175_CR13","first-page":"3770","volume":"61","author":"K Tsukasaki","year":"2001","unstructured":"Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, Ikeda S, Tomonaga M, Koeffler HP: Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia\/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 2001, 61 (9): 3770-3774.","journal-title":"Cancer Res"},{"issue":"7","key":"2175_CR14","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, et al: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 1999, 96 (7): 3848-3853. 10.1073\/pnas.96.7.3848.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2175_CR15","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","volume":"165","author":"KJ Jeffery","year":"2000","unstructured":"Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, et al: The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000, 165 (12): 7278-7284.","journal-title":"J Immunol"},{"issue":"5","key":"2175_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-0039.1991.tb01877.x","volume":"37","author":"Y Nishimura","year":"1991","unstructured":"Nishimura Y, Okubo R, Minato S, Itoyama Y, Goto I, Mori M, Hirayama K, Sasazuki T: A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese. Tissue Antigens. 1991, 37 (5): 230-231. 10.1111\/j.1399-0039.1991.tb01877.x.","journal-title":"Tissue Antigens"},{"issue":"12","key":"2175_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0198-8859(00)00182-8","volume":"61","author":"M Nishimura","year":"2000","unstructured":"Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, Kuroda Y, Kawakami H, Uchiyama T: Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol. 2000, 61 (12): 1262-1269. 10.1016\/S0198-8859(00)00182-8.","journal-title":"Hum Immunol"},{"issue":"8","key":"2175_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0198-8859(02)00419-6","volume":"63","author":"M Nishimura","year":"2002","unstructured":"Nishimura M, Matsuoka M, Maeda M, Mizuta I, Mita S, Uchino M, Matsui M, Kuroda Y, Kawakami H, Kaji R, et al: Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy. Hum Immunol. 2002, 63 (8): 696-700. 10.1016\/S0198-8859(02)00419-6.","journal-title":"Hum Immunol"},{"issue":"7","key":"2175_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/423942","volume":"190","author":"AH Sabouri","year":"2004","unstructured":"Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, et al: Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis. 2004, 190 (7): 1279-1285. 10.1086\/423942.","journal-title":"J Infect Dis"},{"issue":"12)","key":"2175_CR20","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/jmv.21341","volume":"80","author":"SR Gadelha","year":"2008","unstructured":"Gadelha SR, Junior Alcantara LC, Costa GC, Acosta AX, Rios D, Kashima S, Covas DT, Galvao-Castro B: Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis in Brazilian individuals. J Med Virol. 2008, 80 (12)): 2141-2146.","journal-title":"J Med Virol"},{"issue":"7262","key":"2175_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al: Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009, 461 (7262): 399-401. 10.1038\/nature08309.","journal-title":"Nature"},{"issue":"10","key":"2175_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, et al: IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009, 41 (10): 1100-1104. 10.1038\/ng.447.","journal-title":"Nat Genet"},{"issue":"10","key":"2175_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, et al: Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009, 41 (10): 1105-1109. 10.1038\/ng.449.","journal-title":"Nat Genet"},{"issue":"1","key":"2175_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","volume":"139","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, et al: Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology. 2010, 139 (1): 120-129. 10.1053\/j.gastro.2010.04.013. e118","journal-title":"Gastroenterology"},{"issue":"4","key":"2175_CR25","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","volume":"138","author":"A Rauch","year":"2010","unstructured":"Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, et al: Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology. 2010, 138 (4): 1338-1345. 10.1053\/j.gastro.2009.12.056. 1345 e1331-1337","journal-title":"Gastroenterology"},{"issue":"8","key":"2175_CR26","doi-asserted-by":"publisher","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","volume":"24","author":"NI Rallon","year":"2010","unstructured":"Rallon NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, et al: Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients. AIDS. 2010, 24 (8): F23-F29. 10.1097\/QAD.0b013e3283391d6d.","journal-title":"AIDS"},{"issue":"5","key":"2175_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/infdis\/jiq098","volume":"203","author":"J Nattermann","year":"2011","unstructured":"Nattermann J, Vogel M, Nischalke HD, Danta M, Mauss S, Stellbrink HJ, Baumgarten A, Mayr C, Bruno R, Tural C, et al: Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. J Infect Dis. 2011, 203 (5): 595-601. 10.1093\/infdis\/jiq098.","journal-title":"J Infect Dis"},{"issue":"1","key":"2175_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis343","volume":"55","author":"A Trevino","year":"2012","unstructured":"Trevino A, Lopez M, Vispo E, Aguilera A, Ramos JM, Benito R, Roc L, Eiros JM, de Mendoza C, Soriano V: Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms. Clin Infect Dis. 2012, 55 (1): e1-e4. 10.1093\/cid\/cis343.","journal-title":"Clin Infect Dis"},{"key":"2175_CR29","first-page":"191","volume-title":"Human Retrovirology: HTLV","author":"Osame","year":"1990","unstructured":"Osame: Review of WHO Kagoshima Meeting and diagnostic guidelines for HAM\/TSP. Human Retrovirology: HTLV. Edited by: Blattner W. 1990, New York: Raven, 191-197."},{"key":"2175_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1743-422X-8-535","volume":"8","author":"WK Neto","year":"2011","unstructured":"Neto WK, Da-Costa AC, de Oliveira AC, Martinez VP, Nukui Y, Sabino EC, Sanabani SS: Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers. Virol J. 2011, 8: 535-10.1186\/1743-422X-8-535.","journal-title":"Virol J"},{"issue":"2","key":"2175_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.virusres.2012.02.018","volume":"165","author":"C Scagnolari","year":"2012","unstructured":"Scagnolari C, Midulla F, Riva E, Monteleone K, Solimini A, Bonci E, Cangiano G, Papoff P, Moretti C, Pierangeli A, et al: Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis. Virus Res. 2012, 165 (2): 236-240. 10.1016\/j.virusres.2012.02.018.","journal-title":"Virus Res"},{"issue":"6","key":"2175_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, et al: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998, 4 (6): 586-593. 10.3109\/13550289809114225.","journal-title":"J Neurovirol"},{"issue":"8","key":"2175_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, et al: Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010, 116 (8): 1211-1219. 10.1182\/blood-2009-12-257410.","journal-title":"Blood"},{"issue":"43","key":"2175_CR34","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1038\/sj.onc.1203870","volume":"19","author":"AS Gabet","year":"2000","unstructured":"Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, Gessain A, Clity E, Joubert M, Wattel E: High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000, 19 (43): 4954-4960. 10.1038\/sj.onc.1203870.","journal-title":"Oncogene"},{"issue":"2","key":"2175_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-2257.2003.00503.x","volume":"25","author":"S Kamihira","year":"2003","unstructured":"Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, Hirakata Y, Yamada Y: Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003, 25 (2): 111-117. 10.1046\/j.1365-2257.2003.00503.x.","journal-title":"Clin Lab Haematol"},{"issue":"5","key":"2175_CR36","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1086\/315088","volume":"180","author":"A Manns","year":"1999","unstructured":"Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, Cranston B, Maloney E, Welles SL, Blattner WA, et al: Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis. 1999, 180 (5): 1487-1493. 10.1086\/315088.","journal-title":"J Infect Dis"},{"issue":"4","key":"2175_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF03256286","volume":"12","author":"JR Jonsson","year":"2008","unstructured":"Jonsson JR, Purdie DM, Clouston AD, Powell EE: Recognition of genetic factors influencing the progression of hepatitis C: potential for personalized therapy. Mol Diagn Ther. 2008, 12 (4): 209-218.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"2175_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/QAD.0b013e328341b84e","volume":"25","author":"NI Rallon","year":"2011","unstructured":"Rallon NI, Restrepo C, Naggie S, Lopez M, Del Romero J, Goldstein D, McHutchison J, Soriano V, Benito JM: Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline. AIDS. 2011, 25 (2): 269-271. 10.1097\/QAD.0b013e328341b84e.","journal-title":"AIDS"},{"issue":"11","key":"2175_CR39","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/657146","volume":"202","author":"MP Martin","year":"2010","unstructured":"Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL: IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis. 2010, 202 (11): 1749-1753. 10.1086\/657146.","journal-title":"J Infect Dis"},{"key":"2175_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1743-422X-9-40","volume":"9","author":"S Kamihira","year":"2012","unstructured":"Kamihira S, Usui T, Ichikawa T, Uno N, Morinaga Y, Mori S, Nagai K, Sasaki D, Hasegawa H, Yanagihara K, et al: Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus. Virol J. 2012, 9: 40-10.1186\/1743-422X-9-40.","journal-title":"Virol J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-374\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:45:47Z","timestamp":1548204347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-374","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"374"}}